Abstract
Greystone Research Associates is pleased to announce the publication of a new
market study. ‘Drug Self-Administration to 2018: Drug Products, Indications,
Markets and Forecasts’ is a comprehensive evaluation and analysis of the
technology, products and participants providing the driving force behind this
evolving segment of the drug delivery sector. The study is designed to provide
drug company decision makers, drug delivery developers, device designers,
healthcare marketers, and supply chain participants with a detailed
understanding of the economics, technologies, disease segments, and commercial
opportunities for prescription drugs packaged and supplied for patient
self-administration. Provider organization business managers, healthcare
administrators and investors will also benefit from this study.
Product Strategies and the Shift in Patient Care to Self-Administration
A number of factors are converging to create both risk and opportunity for
drug makers and their delivery device partners. These include new classes of
drugs for previously refractory conditions, growing trend toward
self-administration for chronic diseases, shifting patient demographics in
industrial countries, caregiver safety legislation, and continued pressure to
control healthcare costs. These factors are giving rise to a new generation of
sophisticated, application-specific injection, inhalation and transdermal drug
products designed to satisfy caregiver and patient preferences while
addressing managed care initiatives and the formulation limitations of new
classes of therapeutic drugs. Because of their ability to safely and reliably
satisfy treatment protocols and compliance goals, non-oral drug delivery
products will have a significant impact on the future of drug
selfadministration.
Feature Summary
- Provides detailed analysis of drug self-administration market segments,
market dynamics and market demographics
- Analyzes therapeutic demand drivers and evaluates commercial drug products
in more than two dozen major self-administration therapeutic segments
- Analyzes design factors, material selection issues, technologies and
market development issues for injection devices, inhalation devices and
transdermal drug products designed for self-administration
- Charts product data, market share, and forecasts to 2018
- Profiles self-administration drug product and device participants, their
product development activities, business strategies, and corporate alliances
and affiliations
- Assesses the importance of pharma-device alliances and design partnerships
on drug self-administration commercialization
- Evaluates the impact of economic, technology, and regulatory factors
Methodology
Research methodology is based on primary research in the form of in-depth
interviews with key market participants, technology developers, distributors,
industry experts, and market influencers, a list that includes regulatory
officials, industry trade groups, and materials standards organizations.
Primary data is evaluated and normalized against secondary sources including
trade journal articles, technical literature, industry publications, company
data sheets and published information, and statistical data from government
agencies and trade associations.
Forecasts and projections of market demand and future market activity are
derived using standard modeling and statistical techniques.
About Greystone Research Associates
Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis.
Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
Table of Contents
Executive Summary
The Market Opportunity
- Drug Market Dynamics
- Evolving Drug Market Factors
- Chronic Disease and Self-administration
- Managed Care and Prescribing Trends
- Drug Self-Administration Demand Factors
Drug Self-Administration Product Segments and Market Drivers
Injectable Drug Self-Administration Products
- Prefilled Syringes (PFS)
- Pen Injectors
- Needle-free Injectors (NFI)
Inhaled Drug Self-Administration Products
- The Upper Respiratory Market
- The Systemic/Deep Lung Market
- Inhaler Product Segments
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nebulizers
- Performance Factors
Transdermal Drug Products
- Market Sector Dynamics
- Prescription Patch Design & Technology
- Prescription Patch Development Factors
- Key Transdermal Therapeutic Markets
- Transdermal Product Company Profiles
Drug Self-Administration - Therapeutic Sector Analysis & Forecasts
- ADHD
- Anticoagulants
- Arthritis
- Asthma/COPD
- Cardiovascular
- Contraception
- Cystic Fibrosis
- Diabetes
- Hematopoietics
- Hepatitis
- Hormone Therapy/Replacement
- Multiple Sclerosis
- Neurology
- Osteoporosis
- Pain Management
- Psoriasis
- Sexual Health
Company Profiles
Drug Self-Administration Markets to 2018: Drug Products, Indications, Markets and Forecasts published by Greystone Research Associates in March 12, 2013. This report price starts from US $ 4850.
The contents of this page may be different from the latest version. Please contact us for details.
